CRH plc (CRH)
NYSEMaterialsBuilding MaterialsSnapshot 2026-07-07
$106.19-1.30%
Close 2026-07-07 · 1-day change
Reading CRH? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CRH free→NYSEMaterialsBuilding MaterialsSnapshot 2026-07-07
Reading CRH? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CRH free→QuarterlyIQ Insights · CRH
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 13 valuation methods, at three horizons. Current price $106.19. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $106 CRH trades at 19× p/e, below its 24× p/e peer median, but our blended $95 fair value sits below the price. It's a high-confidence read. Even valued only for durable growth at sustainable margins, it's worth about $121 — above today's price, so the premium reflects that growth case, not pure multiple expansion. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price you pay about 21% over what the business is worth with no growth; closing that gap needs roughly 6.0 years of the forecast growth to come through. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $4.83/sh owner earnings.
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| dcf fcfe | 12M | $62.01 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $48.57 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $17.69 | — | — | TTM | high |
| graham number | 12M | $66.59 | — | — | TTM | high |
| Mgmt guidance | 12M | $137.04 | 23.5 | 5.83 | Mgmt | high |
| Peer EV/EBITDA | 12M | $103.08 | 14.3 | 8.87 | TTM | high |
| Peer P/FCF | 12M | $138.14 | 32.1 | 4.30 | TTM | high |
| Peer P/E | 12M | $128.39 | 23.5 | 5.46 | TTM | high |
| Peer P/S | 12M | $119.40 | 2.1 | 56.93 | TTM | high |
| PEG | 12M | $151.53 | 27.7 | 5.46 | TTM | high |
| residual income | 12M | $44.51 | — | — | TTM | high |
| Own P/E history | 12M | $108.06 | 19.8 | 5.46 | TTM | high |
| triangulated | 12M | $127.20 | 23.5 | 5.41 | Triangulated | high |
| Mgmt guidance | 3Y | $212.28 | 23.5 | 9.03 | Mgmt(prov.) | medium |
| Peer P/FCF | 3Y | $140.23 | 32.1 | 4.37 | Hist. CAGR(prov.) | medium |
| Mgmt guidance | 5Y | $284.19 | 23.5 | 12.09 | Mgmt(prov.) | medium |
| Peer P/FCF | 5Y | $141.64 | 32.1 | 4.41 | Hist. CAGR(prov.) | medium |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.